ArticleFrontiers in pharmacology2024

Risks of malignancies related to disease-modifying antirheumatic drugs in rheumatoid arthritis: a pharmacovigilance analysis using the FAERS database.

Wan Xiong et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.